Cargando…
Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations
Background: In patients with diabetes, transplantation of stem cells increases C-peptide levels and induces insulin independence for some period. Today, this positive therapeutic outcome is widely attributed to the well-documented immunomodulatory properties of stem cells. The aim of this study was...
Autores principales: | Tootee, Ali, Nikbin, Behrouz, Nasli Esfahani, Ensieh, Arjmand, Babak, Aghayan, Hamidreza, Qorbani, Mostafa, Ghahari, Aziz, Larijani, Bagher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iran University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448473/ https://www.ncbi.nlm.nih.gov/pubmed/36128298 http://dx.doi.org/10.47176/mjiri.36.34 |
Ejemplares similares
-
Diabetes management during Ramadan amid Covid-19 pandemic
por: Tootee, Ali, et al.
Publicado: (2020) -
Evaluation of fetal cell transplantation safety in treatment of diabetes: a three-year follow-up
por: Nasli-Esfahani, Ensieh, et al.
Publicado: (2015) -
Amino acid profiling in the gestational diabetes mellitus
por: Rahimi, Najmeh, et al.
Publicado: (2017) -
Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence
por: Bandarian, Fatemeh, et al.
Publicado: (2023) -
Critical roles of cytokine storm and bacterial infection in patients with COVID-19: therapeutic potential of mesenchymal stem cells
por: Arjmand, Babak, et al.
Publicado: (2023)